Offer - Urjas Oil for just ₹ 1 X
Gynapres L is a prescription medicine that is available as a Tablet. High BP are some of its major therapeutic uses. Other than this, Gynapres L has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Gynapres L is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Gynapres L can also lead to other problems, which have been listed below. Such side effects of Gynapres L normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Gynapres L is Severe for pregnant women and Mild for women who are breastfeeding. It is important to know if Gynapres L has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gynapres L related warnings section.
Individuals suffering from medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Gynapres L since this can cause severe adverse effects. The section on Gynapres L contraindications lists all such conditions.
Besides this, Gynapres L may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Gynapres L is not safe while driving, and is not addiction.
Gynapres L is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Geriatric |
|
Adult |
|
Is the use of Gynapres L safe for pregnant women?
Gynapres L should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Gynapres L safe during breastfeeding?
Gynapres L may have very limited harmful effects for breastfeeding women.
What is the effect of Gynapres L on the Kidneys?
Using Gynapres L does not have any harmful effects on kidneys.
What is the effect of Gynapres L on the Liver?
Gynapres L is rarely harmful for the liver.
What is the effect of Gynapres L on the Heart?
Very few cases of side effects of Gynapres L on the heart have been reported.
Gynapres L should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Gynapres L unless your doctor advises you to do so -
Is this Gynapres L habit forming or addictive?
Forming a habit of Gynapres L has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Gynapres L you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Gynapres L is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Gynapres L for mental disorders.
Interaction between Food and Gynapres L
Eating certain foods may increase the time it takes Gynapres L to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Gynapres L
Consumption of alcohol and Gynapres L together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trandate® (labetalol hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 735-737